AcouSort AB (ACOU) - Total Assets
Based on the latest financial reports, AcouSort AB (ACOU) holds total assets worth Skr21.86 Million SEK (≈ $2.35 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See AcouSort AB shareholders equity for net asset value and shareholders' equity analysis.
AcouSort AB - Total Assets Trend (2013–2024)
This chart illustrates how AcouSort AB's total assets have evolved over time, based on quarterly financial data.
AcouSort AB - Asset Composition Analysis
Current Asset Composition (December 2024)
AcouSort AB's total assets of Skr21.86 Million consist of 63.1% current assets and 36.9% non-current assets.
| Asset Category | Amount (SEK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr0.00 | 29.0% |
| Accounts Receivable | Skr1.69 Million | 13.7% |
| Inventory | Skr2.52 Million | 20.5% |
| Property, Plant & Equipment | Skr0.00 | 0.0% |
| Intangible Assets | Skr4.45 Million | 36.1% |
| Goodwill | Skr0.00 | 0.0% |
Asset Composition Trend (2013–2024)
This chart illustrates how AcouSort AB's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market cap of AcouSort AB.
Key Asset Composition Facts
- Current vs. Non-Current Assets: AcouSort AB's current assets represent 63.1% of total assets in 2024, a decrease from 100.0% in 2013.
- Cash Position: Cash and equivalents constituted 29.0% of total assets in 2024, down from 87.6% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 36.0% of total assets, an increase from 0.0% in 2013.
- Asset Diversification: The largest asset category is intangible assets at 36.1% of total assets.
AcouSort AB Competitors by Total Assets
Key competitors of AcouSort AB based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Argen-X
F:1AE
|
Germany | €7.18 Billion |
|
Tubize-Fin
BR:TUB
|
Belgium | €1.93 Billion |
|
BrightGene Bio Medical Technology C
SHG:688166
|
China | CN¥5.38 Billion |
|
Dashenlin Pharm Grp Co Ltd
SHG:603233
|
China | CN¥26.08 Billion |
|
Staidson Beijing Biopharma
SHE:300204
|
China | CN¥1.26 Billion |
|
Tibet Cheezheng Tibetan Medicine Co Ltd
SHE:002287
|
China | CN¥6.64 Billion |
|
Ardelyx Inc
NASDAQ:ARDX
|
USA | $486.17 Million |
|
Xiangxue Pharmaceutical
SHE:300147
|
China | CN¥7.36 Billion |
AcouSort AB - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 5.33 | 2.13 | 2.94 |
| Quick Ratio | 4.51 | 1.77 | 2.75 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Skr13.88 Million | Skr7.34 Million | Skr6.96 Million |
AcouSort AB - Advanced Valuation Insights
This section examines the relationship between AcouSort AB's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.23 |
| Latest Market Cap to Assets Ratio | 0.73 |
| Asset Growth Rate (YoY) | -64.3% |
| Total Assets | Skr12.32 Million |
| Market Capitalization | $8.97 Million USD |
Valuation Analysis
Below Book Valuation: The market values AcouSort AB's assets below their book value (0.73x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: AcouSort AB's assets decreased by 64.3% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for AcouSort AB (2013–2024)
The table below shows the annual total assets of AcouSort AB from 2013 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | Skr12.32 Million ≈ $1.33 Million |
-64.29% |
| 2023-12-31 | Skr34.51 Million ≈ $3.71 Million |
-19.09% |
| 2022-12-31 | Skr42.66 Million ≈ $4.59 Million |
+16.67% |
| 2021-12-31 | Skr36.56 Million ≈ $3.93 Million |
+177.58% |
| 2020-12-31 | Skr13.17 Million ≈ $1.42 Million |
+63.92% |
| 2019-12-31 | Skr8.04 Million ≈ $864.69K |
-53.93% |
| 2018-12-31 | Skr17.44 Million ≈ $1.88 Million |
+252.52% |
| 2017-12-31 | Skr4.95 Million ≈ $532.38K |
-58.91% |
| 2016-12-31 | Skr12.04 Million ≈ $1.30 Million |
+4517.90% |
| 2015-12-31 | Skr260.70K ≈ $28.06K |
-71.67% |
| 2014-12-31 | Skr920.08K ≈ $99.02K |
-61.88% |
| 2013-12-31 | Skr2.41 Million ≈ $259.72K |
-- |
About AcouSort AB
AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC … Read more